Fibroadenomas are caused primarily by an overgrowth of breast tissue driven by estrogen and progesterone. These hormones stimulate both the glandular tissue and the connective tissue (stroma) surrounding it, leading to a firm, smooth lump that moves easily under the skin. They are the most common benign breast lumps, typically appearing in women between their late teens and early 30s, though they can develop at any age.
How Hormones Drive Fibroadenoma Growth
Estrogen is the primary hormonal driver. It works through two main types of receptors on breast cells, each triggering different signaling pathways that promote cell growth and division. A third receptor type mediates faster, more immediate effects of estrogen on breast tissue. When these receptors are activated, they set off a chain of changes in gene expression that leads to excess tissue growth in a localized area, forming the characteristic rubbery lump.
Progesterone plays a supporting role, interacting with estrogen to further stimulate breast tissue proliferation. Growth factors produced locally in the breast tissue add another layer of complexity, amplifying the hormonal signals. This is why fibroadenomas are most common during the reproductive years, when estrogen and progesterone levels are highest. It also explains why these lumps tend to grow during pregnancy, when hormone levels surge, and often shrink after menopause, when hormone production drops significantly.
Women taking hormonal contraceptives before age 20 may have a somewhat higher likelihood of developing fibroadenomas, likely because of the added hormonal stimulation during a period when breast tissue is still developing and highly responsive.
Why Some People Get Them and Others Don’t
Despite the clear hormonal connection, not every woman with normal estrogen levels develops a fibroadenoma. The difference likely comes down to how sensitive an individual’s breast tissue is to hormonal signals. Some breast tissue simply has more estrogen receptors or more responsive signaling pathways, making it more prone to localized overgrowth. Genetics may influence this sensitivity, which is why fibroadenomas sometimes run in families, though no single gene has been identified as a direct cause.
There’s no strong evidence linking fibroadenomas to diet, caffeine, exercise, or stress. These lumps are not caused by anything you did or didn’t do. They develop because of the normal hormonal environment in your body interacting with tissue that happens to be more responsive in a particular area of the breast.
Simple vs. Complex Fibroadenomas
Most fibroadenomas are classified as “simple,” meaning they contain uniform tissue without unusual internal features. These make up the majority of cases and carry no meaningful increase in breast cancer risk.
Complex fibroadenomas are less common and contain one or more additional features: tiny calcium deposits, small cysts larger than 3 mm, or specific tissue changes like sclerosing adenosis (a type of dense tissue overgrowth). Among complex fibroadenomas studied in one series, sclerosing adenosis was present in 57% of cases, making it the most frequent complex feature. Complex fibroadenomas carry a slightly elevated breast cancer risk compared to having no breast lumps at all, but the absolute increase is small.
What a Fibroadenoma Feels Like
Fibroadenomas typically present as a firm, smooth, rubbery lump that slides easily under your fingers. They’re usually painless, though some women notice mild tenderness, especially before a menstrual period. Most are between 1 and 3 centimeters, roughly the size of a marble to a grape, though they can occasionally grow larger. They have well-defined edges, which is one reason they feel so distinct from the surrounding breast tissue.
On ultrasound, fibroadenomas tend to appear oval-shaped with smooth, well-defined borders and lie parallel to the skin surface. Nearly 98% of fibroadenomas show this parallel orientation, compared to about 84% of certain cancers. That smooth, oval appearance with clear margins is one of the key features that helps distinguish them from concerning masses, though imaging alone isn’t always enough to confirm the diagnosis.
When Monitoring Is Enough
Small, biopsy-confirmed fibroadenomas under 2 cm are typically monitored with periodic imaging rather than removed. This is standard practice because they’re benign, often stay the same size for years, and may even shrink on their own over time. Many women live with fibroadenomas indefinitely without any problems.
Removal is generally recommended when a fibroadenoma is 2 to 3 cm or larger at diagnosis, or when it shows growth on follow-up imaging. The size threshold exists mainly because larger lumps have a higher chance of actually being a phyllodes tumor, a rarer breast growth that looks similar on imaging but behaves differently and needs surgical removal. At some institutions, the threshold for recommending surgical consultation is as low as 2 cm to minimize the chance of missing a phyllodes tumor.
Cryoablation as an Alternative to Surgery
For fibroadenomas under 4 cm, cryoablation offers a nonsurgical option. The procedure uses extreme cold delivered through a small probe to destroy the fibroadenoma tissue in place. It’s done under local anesthesia, and you go home the same day with no downtime. In one study of 125 treated fibroadenomas, the complete treatment rate was 97.6%, with a median volume reduction of nearly 93% at roughly 16 months of follow-up. Only one adverse event was reported across all patients: a minor skin burn that resolved on its own. The American Society of Breast Surgeons has approved cryoablation for fibroadenomas under 4 cm, finding it comparable in safety and effectiveness to open surgical excision.
Changes During Pregnancy and Menopause
If you already have a fibroadenoma and become pregnant, expect it to grow. The dramatic rise in estrogen and progesterone during pregnancy directly stimulates the same receptors that caused the fibroadenoma to form in the first place. This growth is benign and expected, though your doctor may want to monitor it more closely during and after pregnancy.
After menopause, the opposite happens. As estrogen levels fall, many fibroadenomas gradually shrink and may become less noticeable or even disappear entirely. Some older fibroadenomas develop calcifications over time, which can show up on mammograms. These calcifications are typically coarse and easy to distinguish from the type associated with breast cancer, but they may still prompt additional imaging the first time they’re noticed.